How KPV Works in Research Models
KPV is a tripeptide (Lys-Pro-Val) derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH). Researchers have studied it in preclinical models for anti-inflammatory activity through NF-kB pathway inhibition and melanocortin receptor signaling. Published research has primarily examined KPV in the context of inflammatory bowel disease models, dermal inflammation, and mucosal immune regulation. Its small size enables research on gut epithelial penetration and local anti-inflammatory activity in gastrointestinal models.
Mechanism Steps in Research Models
How researchers have characterized KPV activity in published preclinical studies.
Melanocortin Receptor Activation
KPV activates MC1R and MC3R through its alpha-MSH C-terminal sequence. Published research has characterized this receptor binding and documented downstream anti-inflammatory gene expression changes through cAMP-mediated NF-kB pathway modulation in stimulated immune cell culture systems.
NF-kB Pathway Inhibition
Research has documented KPV inhibiting NF-kB nuclear translocation in inflammatory cell culture models, measured through EMSA and reporter gene assays. Published studies have characterized this NF-kB inhibition as a primary mechanism for downstream reductions in pro-inflammatory cytokine production documented in KPV research.
Pro-inflammatory Cytokine Reduction
Cell culture research in stimulated macrophage, epithelial, and immune cell models has documented KPV reducing TNF-alpha, IL-6, and IL-8 production measured through ELISA. Published inflammatory bowel disease model studies have characterized cytokine reduction endpoints in the context of colonic inflammation paradigms.
Gut Epithelial Penetration
Research has examined the capacity of KPV to penetrate gut epithelial barriers in cell culture transport models, documenting transcellular movement that supports local anti-inflammatory activity in gut mucosa. Published studies have used Caco-2 monolayer transport assays to characterize this penetration property.
Research Observations
Key findings documented in published preclinical studies.
Inflammatory Bowel Disease Models
Published preclinical colitis studies using DSS and TNBS rodent models have documented KPV reducing colon inflammation measured through histological scoring, mucosal cytokine content, and macroscopic disease activity endpoints.
Skin Inflammation Research
Dermal inflammation models have documented KPV reducing skin inflammatory cell infiltration, edema, and pro-inflammatory cytokine expression in treated groups relative to vehicle controls, measured through histology and cytokine quantification.
NF-kB Pathway Studies
Cell culture research using LPS-stimulated macrophages and epithelial cells has documented KPV inhibiting NF-kB activation with corresponding reductions in downstream inflammatory gene expression measured through reporter assays and cytokine ELISA.
Gut Mucosal Immune Research
Research examining gut mucosal immune regulation has documented KPV interaction with gut epithelial immune signaling, with published data on mucosal cytokine modulation and epithelial barrier function in colitis model systems.
Signaling Summary
In research models, KPV activates melanocortin receptors with documented downstream NF-kB pathway inhibition and reduction of pro-inflammatory cytokine production. Researchers have characterized its anti-inflammatory effects through cytokine quantification assays measuring TNF-alpha, IL-6, and IL-8 reductions in stimulated cell culture systems and inflammatory animal models. Published research also documents KPV interaction with formyl peptide receptor 2, a pattern recognition receptor with established roles in inflammation resolution.
Research Connections
Frequently Asked Questions
Source Research-Grade KPV
Spartan Peptides supplies research-grade KPV at least 98% HPLC-verified purity with Certificate of Analysis. Domestic US supply, same-day dispatch before 2 PM. For in vitro research use only.
For in vitro research use only. Not for human consumption.